236 related articles for article (PubMed ID: 35984862)
1. Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans.
Gaeta AL; Nourse JB; Willicott K; McKay LE; Keogh CM; Peter K; Russell SN; Hamamichi S; Berkowitz LA; Caldwell KA; Caldwell GA
PLoS Genet; 2022 Aug; 18(8):e1010115. PubMed ID: 35984862
[TBL] [Abstract][Full Text] [Related]
2. Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson's disease models.
Nourse JB; Russell SN; Moniz NA; Peter K; Seyfarth LM; Scott M; Park HA; Caldwell KA; Caldwell GA
Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2210712120. PubMed ID: 36745808
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling.
Kautu BB; Carrasquilla A; Hicks ML; Caldwell KA; Caldwell GA
Neurosci Lett; 2013 Apr; 541():116-9. PubMed ID: 23485787
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific overexpression of systemic RNA interference components limits lifespan in C. elegans.
Camara H; Inan MD; Vergani-Junior CA; Pinto S; Knittel TL; Salgueiro WG; Tonon-da-Silva G; Ramirez J; de Moraes D; Braga DL; De-Souza EA; Mori MA
Gene; 2024 Feb; 895():148014. PubMed ID: 37984536
[TBL] [Abstract][Full Text] [Related]
5. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
[TBL] [Abstract][Full Text] [Related]
6. RNAi of cat-2, a putative tyrosine hydroxylase, increases alpha synuclein aggregation and associated effects in transgenic C. elegans.
Kaur S; Sammi SR; Jadiya P; Nazir A
CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):387-94. PubMed ID: 22483307
[TBL] [Abstract][Full Text] [Related]
7. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
[TBL] [Abstract][Full Text] [Related]
8. SID-4/NCK-1 is important for dsRNA import in Caenorhabditis elegans.
Bhatia S; Hunter CP
G3 (Bethesda); 2022 Nov; 12(11):. PubMed ID: 36165710
[TBL] [Abstract][Full Text] [Related]
9. Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease.
Harrington AJ; Knight AL; Caldwell GA; Caldwell KA
Methods; 2011 Mar; 53(3):220-5. PubMed ID: 21195766
[TBL] [Abstract][Full Text] [Related]
10. Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.
Cheon SM; Jang I; Lee MH; Kim DK; Jeon H; Cha DS
Pharm Biol; 2017 Dec; 55(1):481-486. PubMed ID: 27937005
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease.
Harrington AJ; Yacoubian TA; Slone SR; Caldwell KA; Caldwell GA
J Neurosci; 2012 Feb; 32(6):2142-53. PubMed ID: 22323726
[TBL] [Abstract][Full Text] [Related]
12. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.
Jadiya P; Chatterjee M; Sammi SR; Kaur S; Palit G; Nazir A
Biochem Biophys Res Commun; 2011 Sep; 413(2):306-10. PubMed ID: 21889494
[TBL] [Abstract][Full Text] [Related]
13. Export of RNA silencing from C. elegans tissues does not require the RNA channel SID-1.
Jose AM; Smith JJ; Hunter CP
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2283-8. PubMed ID: 19168628
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model.
Ray A; Martinez BA; Berkowitz LA; Caldwell GA; Caldwell KA
Cell Death Dis; 2014 Jan; 5(1):e984. PubMed ID: 24407237
[TBL] [Abstract][Full Text] [Related]
15. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.
Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M
Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053
[TBL] [Abstract][Full Text] [Related]
16. A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans.
Jadiya P; Fatima S; Baghel T; Mir SS; Nazir A
Mol Neurobiol; 2016 Nov; 53(9):6288-6300. PubMed ID: 26567108
[TBL] [Abstract][Full Text] [Related]
17. Enhanced neuronal RNAi in C. elegans using SID-1.
Calixto A; Chelur D; Topalidou I; Chen X; Chalfie M
Nat Methods; 2010 Jul; 7(7):554-9. PubMed ID: 20512143
[TBL] [Abstract][Full Text] [Related]
18. SID-1 Functions in Multiple Roles To Support Parental RNAi in
Wang E; Hunter CP
Genetics; 2017 Oct; 207(2):547-557. PubMed ID: 28751423
[TBL] [Abstract][Full Text] [Related]
19. SID-1 Domains Important for dsRNA Import in
Whangbo JS; Weisman AS; Chae J; Hunter CP
G3 (Bethesda); 2017 Dec; 7(12):3887-3899. PubMed ID: 29025917
[TBL] [Abstract][Full Text] [Related]
20. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease.
Johnson WM; Yao C; Siedlak SL; Wang W; Zhu X; Caldwell GA; Wilson-Delfosse AL; Mieyal JJ; Chen SG
Hum Mol Genet; 2015 Mar; 24(5):1322-35. PubMed ID: 25355420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
